These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19337871)

  • 1. Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients.
    Miyazaki S; Takahashi A; Itoh K; Ishitani M; Dairaku M; Togashi M; Mikami R; Attwood D
    Drug Dev Ind Pharm; 2009 Jul; 35(7):780-7. PubMed ID: 19337871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
    Itoh K; Hatakeyama T; Shimoyama T; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2011 Jul; 37(7):790-7. PubMed ID: 21405940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrageenan gels for oral sustained delivery of acetaminophen to dysphagic patients.
    Miyazaki S; Ishitani M; Takahashi A; Shimoyama T; Itoh K; Attwood D
    Biol Pharm Bull; 2011; 34(1):164-6. PubMed ID: 21212538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
    Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the degree of esterification on the release characteristics of in situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Miyazaki S; Murofushi H; Shimoyama T; Itoh K; Kobayashi M; Attwood D
    Pharm Dev Technol; 2013; 18(5):1259-64. PubMed ID: 22304683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients.
    Sharma S; Sarkar G; Srestha B; Chattopadhyay D; Bhowmik M
    Int J Biol Macromol; 2019 Aug; 134():864-868. PubMed ID: 31102679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol.
    Miyazaki S; Kubo W; Itoh K; Konno Y; Fujiwara M; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2005 Jun; 297(1-2):38-49. PubMed ID: 15907595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations.
    Miyazaki S; Endo K; Kawasaki N; Kubo W; Watanabe H; Attwood D
    Drug Dev Ind Pharm; 2003 Feb; 29(2):113-9. PubMed ID: 12648007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Kubo W; Konno Y; Miyazaki S; Attwood D
    Drug Dev Ind Pharm; 2004 Jul; 30(6):593-9. PubMed ID: 15285332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
    Miyazaki S; Kawasaki N; Endo K; Attwood D
    J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.
    Kubo W; Miyazaki S; Attwood D
    Int J Pharm; 2003 Jun; 258(1-2):55-64. PubMed ID: 12753753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations.
    Itoh K; Kubo W; Fujiwara M; Hirayama T; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2006 Apr; 312(1-2):37-42. PubMed ID: 16473484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermally reversible xyloglucan gels as vehicles for oral drug delivery.
    Kawasaki N; Ohkura R; Miyazaki S; Uno Y; Sugimoto S; Attwood D
    Int J Pharm; 1999 Apr; 181(2):227-34. PubMed ID: 10370218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery.
    Mahajan HS; Tyagi V; Lohiya G; Nerkar P
    Drug Deliv; 2012; 19(5):270-6. PubMed ID: 22823894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gellan gum fluid gels for topical administration of diclofenac.
    Mahdi MH; Conway BR; Mills T; Smith AM
    Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ-gelling gellan formulations as vehicles for oral drug delivery.
    Miyazaki S; Aoyama H; Kawasaki N; Kubo W; Attwood D
    J Control Release; 1999 Aug; 60(2-3):287-95. PubMed ID: 10425334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.